To understand the leukemogenic potential of genetically heterogenous cells residing in the LSC compartment, we sorted putative LSCs (CD34+CD38–) from AML-11 and injected 10,000 cells into NSG mouse (Fig. 5J). This evidence concerns the gene CD38 and acute myeloid leukemia.